ORTHODONTIX INC. 10-KSB 12/31/05

Company

Protalix BioTherapeutics, Inc.

Filed

March 30, 2006

Period of Report

December 31, 2005

Accession Number

0001006281-06-000002

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →